Tobacco & Nicotine
- Eight articles in this issue give readers the unusual opportunity of seeing together the results of multiple clinical trials with a common goal—in this case, identifying effective strategies for implementing tobacco-cessation interventions among hospitalized cigarette smokers. Seven trials are included in a Theme Issue that reports the findings of the NIH-funded Consortium of Hospitals to Advance Research on Tobacco (CHART).1–8 An additional paper outside the Theme Issue reports the findings of an independently funded trial with the same goal.
- The 1998 national multistate Master Settlement Agreement (MSA) with the major cigarette manufacturers in the U.S. cultivated hope that payments from that settlement would be used to fund proven programs to prevent and reduce tobacco use. By 2002, tobacco prevention funding across all states reached an all-time high of nearly $750 million per year. However, that early promise was not sustained. Within just 2 years, state funding for tobacco prevention was reduced by more than $200 million.
- As Governor of the State of Oklahoma, my goal is to create and maintain a happy, healthy, and productive state, but we cannot expect to improve the health of Oklahomans without addressing our state’s number one killer: tobacco. In fact, both of my parents died from smoking-related illnesses. After years of smoking, my father died from heart disease when he was younger than I am today. My mother smoked her whole life. At the age of 73 she had heart surgery, suffered a stroke, and was bedridden for five years before passing away.